Bio Pharma Dive
SEPTEMBER 4, 2020
The licensing deal hands AbbVie exclusive rights to a drug that targets CD47, a protein which has caught the attention of other large drugmakers like Gilead and Celgene.
Pharma Mirror
SEPTEMBER 4, 2020
The first digital session of Medical Device Innovation Summit concludes on a positive note with industry leaders addressing burning topics to promote innovation in the medical equipment industry. From challenges like lack of regulatory systems to its new found potential of manufacturing indigenous products on a large scale, the summit successfully addressed discussions on new.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
SEPTEMBER 4, 2020
While the shot appeared less potent than those being advanced by U.S. and U.K. companies, the Russian vaccine could be used broadly because it doesn't need to be kept frozen.
pharmaphorum
SEPTEMBER 4, 2020
Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan. The French pharma in April joined forces with the UK’s GSK to produce the vaccine, with Sanofi contributing an antigen that produces the immune reaction. Meanwhile GSK is producing the booster that reduces the amount of active ingredient necessary to produce an effect.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
SEPTEMBER 4, 2020
Xtalks.com has been connecting life science professionals through webinars and other media for nearly 20 years. With the introduction of Xtalks Job Search, we’re expanding to offer job postings to the community. By connecting our life science-focused members with leading employers in the pharmaceutical, biotechnology and medical device industries, we aim to offer job seekers, and those who are employed, easy access to exciting new careers.
pharmaphorum
SEPTEMBER 4, 2020
England is to trial population testing for COVID-19 in places such as schools, colleges and busy public spaces. Health secretary Matt Hancock said the government has earmarked an extra £500 million ($552 million) to scale up testing and capacity to launch community pilots as fears mount about as second wave of infections during the winter months. The population testing will be made possible by new test kits capable of giving results within 15 minutes or so.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
SEPTEMBER 4, 2020
Credit: ACS Nano Scientists at Tokyo Institute of Technology (Tokyo Tech, Japan) and Institute of Photonic Sciences (ICFO, Spain) develop a method to generate circularly polarized light from the ultimate symmetrical structure: the sphere. Their approach involves breaking the inherent symmetry of the sphere by electron beam excitation, which allows for precisely controlling the phase […].
Pharma Times
SEPTEMBER 4, 2020
The technique has been used to generate a high-affinity antibody against Arginase 2, an enzyme implicated in major human diseases
Scienmag
SEPTEMBER 4, 2020
Credit: Vanderbilt University Medical Center Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19. Prior studies have shown that using simple, over-the-counter nasal saline irrigations can decrease viral shedding in upper respiratory infections — including other […].
Pharma Times
SEPTEMBER 4, 2020
The findings have validated confidence in the experimental vaccine, the firm noted
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
SEPTEMBER 4, 2020
Credit: Takashi Kobayashi, Tohoku University Quantum bits, or qubits, can hold quantum information much longer now thanks to efforts by an international research team. The researchers have increased the retention time, or coherence time, to 10 milliseconds – 10,000 times longer than the previous record – by combining the orbital motion and spinning inside an […].
XTalks
SEPTEMBER 4, 2020
When is vegan not actually vegan? The answer is subjective and has implications for what are purported to be vegan products. While self-identified vegans don’t all share the same conception of the term, most generally agree that nobody can be 100 percent vegan. Why? Most vegans recognize that every so-called vegan activity, from eating only a plant-based diet to operating an animal sanctuary, is done at the expense of animals.
Scienmag
SEPTEMBER 4, 2020
Credit: Siwen Long Researchers at Karolinska Institutet in Sweden have identified a small neutralizing antibody, a so-called nanobody, that has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has the potential to be developed as an antiviral treatment against COVID-19. The results are published in the journal Nature Communications. […].
pharmaphorum
SEPTEMBER 4, 2020
Microsoft and UK clinical AI company Sensyne Health will use their SENSE clinical algorithms to help provide more personalised care for COVID-19 patients as part of a new agreement with Chelsea & Westminster Hospital. SENSE is a clinical algorithm engine that generates AI algorithms (called SYNEs) for real-time decision support across multiple medical conditions. .
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
SEPTEMBER 4, 2020
Multi-institutional research will identify impediments and possibilities Credit: Photo courtesy UTIA. KNOXVILLE, Tenn. — Researchers from the University of Tennessee Institute of Agriculture and Arizona State University have received a grant for $477,131 to examine consumer preferences for U.S. beef and to estimate beef import demand in select countries within Asia, Europe and Latin America. […].
pharmaphorum
SEPTEMBER 4, 2020
A sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could pose a threat to an inhaled rival from Galen, according to analysts. Investment bank Jefferies ran the books on the company’s $69 million IPO in July and its analysts think that its AI-identified drug dexmedetomidine is likely to be approved thanks to “robust” phase 3 data and the drug’s rapid effects.
Scienmag
SEPTEMBER 4, 2020
Kessler Foundation and University of New Hampshire nTIDE Report–featuring The Chicagoland Entrepreneurship Education for People with Disabilities (CEED) Project, an education and training program for people with disabilities and service providers Credit: Kessler Foundation East Hanover, NJ – September 4, 2020 – August job numbers show improvement for Americans with disabilities, according to today’s National […].
The Pharma Data
SEPTEMBER 4, 2020
Image copyright. Reuters. Image caption. Portugal had previously been removed from the UK’s quarantine list on 20 August. Travellers arriving in Scotland from Portugal will have to self-isolate for 14 days under new quarantine rules that came into force on Saturday morning. Scotland and Wales have added the country to their “quarantine list” – while England and Northern Ireland have not.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
SEPTEMBER 4, 2020
The approach has potential applications in improving optical communications and making currency harder to counterfeit Credit: T. Xu/Nanjing University By shining white light on a glass slide stippled with millions of tiny titanium dioxide pillars, researchers at the National Institute of Standards and Technology (NIST) and their collaborators have reproduced with astonishing fidelity the luminous […].
The Pharma Data
SEPTEMBER 4, 2020
Image copyright. Getty Images. The main test used to diagnose coronavirus is so sensitive it could be picking up fragments of dead virus from old infections, scientists say. Most people are infectious only for about a week, but could test positive weeks afterwards. Researchers say this could be leading to an over-estimate of the current scale of the pandemic.
Scienmag
SEPTEMBER 4, 2020
Credit: Thorsten Mohr, Saarland Universität People infer things beyond what is literally said – and everyone makes his or her own assumptions. This fact poses a major difficulty for computers. For her research project on this topic, Vera Demberg has received the prestigious ERC Starting Grant from the European Research Council, which provides 1.5 million […].
The Pharma Data
SEPTEMBER 4, 2020
Image credit: Adamjennison111 at English Wikipedia. Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters. The researchers vaccinated the hamsters and then exposed them to the virus a month later. The study was published in [ Nature] and concluded: “Our results indicate that the golden hamster is a suitable experimental animal model for investigating infections with SARS-CoV-2, as there is apparent weight loss in the inoculated and n
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
SEPTEMBER 4, 2020
Credit: A. Kvashnin et al./Chemistry of Materials Scientists from the Skolkovo Institute of Science and Technology (Skoltech), Institute of Solid State Chemistry and Mechanochemistry (ISSC SB RAS), Pirogov Medical University and Yerevan State University have predicted new hard and superhard ternary compounds in the tungsten-molybdenum-boron system using computational methods.
The Pharma Data
SEPTEMBER 4, 2020
Image copyright. Getty Images. Attending primary school puts children and staff at no greater risk of contracting coronavirus than staying at home, a study of 131 schools suggests. Tests to find out who had already had the virus found similar levels of antibodies in pupils and teachers. But the study, of 12,000 adults and children in England, was carried out in June and early July, when there were very few cases around.
Scienmag
SEPTEMBER 4, 2020
ERC Starting Grants for Professor Dr Martina Hofmanová and Dr Toni Goßmann Credit: Photo: Bielefeld University /S. Jonek The European Research Council (ERC) has awarded ERC Starting Grants to two researchers from Bielefeld University. They will each receive 1.5 million euros for top-level research in their disciplines. In her project, Professor Dr Martina Hofmanová from […].
The Pharma Data
SEPTEMBER 4, 2020
The technique has been used to generate a high-affinity antibody against Arginase 2, an enzyme implicated in major human diseases. Researchers at the Cancer Research UK-AstraZeneca Antibody Alliance Laboratory in Cambridge, UK, have developed a new technique able to generate an inhibitory, high-affinity antibody against Arginase 2 (ARG2), an enzyme implicated in major human diseases.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
SEPTEMBER 4, 2020
Credit: NASA / JPL An observer standing on Mars would see the planet’s moon Phobos cross the sky from west to east every five hours. Its orbit passes between the sun and any given point on Mars about once each Earth year. Each time it does so, it causes from one to seven solar eclipses […].
The Pharma Data
SEPTEMBER 4, 2020
U.S. Air Force photo/Senior Airman Areca T. Wilson. Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the US will be ready by November. . Saloui was interviewed by Mary Louis Kelly on NPR , and said: “There is a very, very low chance that the trials that are running as we speak could read before the end of October, and therefore there could be – if all other conditions required for an emergency use authorization are met and appro
Scienmag
SEPTEMBER 4, 2020
Credit: NASA Worldview, Earth Observing System Data and Information System (EOSDIS) NASA-NOAA’s Suomi NPP satellite passed over the Philippine Sea on Sept. 4 and provided a visible image of Haishen that had strengthened into a super typhoon. The Visible Infrared Imaging Radiometer Suite (VIIRS) instrument aboard Suomi NPP provided a visible image of Haishen that […].
The Pharma Data
SEPTEMBER 4, 2020
THOUSAND OAKS, Calif. , Sept. 4, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at Citi’s 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020. Murdo Gordon , executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith , executive vice president and chief financial officer, will present at the conference.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
261 
Let's personalize your content